tiprankstipranks
Advertisement
Advertisement
iRhythm should be bought on subpoena weakness, says William Blair
PremiumThe FlyiRhythm should be bought on subpoena weakness, says William Blair
1M ago
iRhythm says received civil investigative demand from DOJ in December
Premium
The Fly
iRhythm says received civil investigative demand from DOJ in December
1M ago
iRhythm price target lowered to $215 from $240 at JPMorgan
Premium
The Fly
iRhythm price target lowered to $215 from $240 at JPMorgan
1M ago
IRTC Earnings this Week: How Will it Perform?
PremiumPre-EarningsIRTC Earnings this Week: How Will it Perform?
1M ago
Top 5 Trending Stocks by Unusual Trading Volume, 1/14/26
Premium
Market News
Top 5 Trending Stocks by Unusual Trading Volume, 1/14/26
2M ago
iRhythm price target raised to $225 from $220 at Wells Fargo
Premium
The Fly
iRhythm price target raised to $225 from $220 at Wells Fargo
2M ago
Evercore ISI upgrades four, downgrades six in MedTech and Tools
PremiumThe FlyEvercore ISI upgrades four, downgrades six in MedTech and Tools
3M ago
iRhythm upgraded to Outperform from In Line at Evercore ISI
Premium
The Fly
iRhythm upgraded to Outperform from In Line at Evercore ISI
3M ago
iRhythm price target lowered to $215 from $230 at Truist
Premium
The Fly
iRhythm price target lowered to $215 from $230 at Truist
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100